medline.ch Respirationstrakt Neoplasie

	Spectral computed tomography in thoracic pathology: A technological and clinical update. Radiologia (Engl Ed) Sutil Berjón R, Peña Gómez ME, Fernández Lobo V, Cobo Ruiz T. PMID: 42711020 [PubMed - indexed for MEDLINE]
	Diffuse skeletal and bone marrow metastases mimicking plasma cell dyscrasia in advanced lung adenocarcinoma. BMJ Case Rep Garg S, Dua R, Koirala R, Panday U. PMID: 42710955 [PubMed - indexed for MEDLINE]
	Rationale and Study Design of the GUIDANCE trial: A Multicenter Phase II Trial of Maintenance Durvalumab and Olaparib After Standard Fist Line Treatment (Carboplatin/Cisplatin, Etoposide, and Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) (AIO-TRK-0124/ass). Clin Lung Cancer Riedel R, Verheyen M, Michels S, Ruge L, Stilianakis S, Jakob C, Scharpenseel H, Scheffler M, Nogova L, Schulmann K, Bozorgmehr F, Grohe C, Griesinger F, Welter V, Fassunke J, Siemanowski-Hrach J, Tolkach Y, Siebolts U, Merkelbach-Bruse S, Büttner R, Wolf J, John F. PMID: 42710416 [PubMed - as supplied by publisher]
	Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges. Cancer Treat Rev Liu Z, Zhang Y, Xue M, Wang Z. PMID: 42710271 [PubMed - as supplied by publisher]
	Non-small cell lung cancer with synchronous oligometastatic disease at the time of initial diagnosis. Impact of multimodal treatment on prognosis. Lung Cancer Schulz C, Swart S, Müller K, Bernhardt D, Safi S, Tufman A, Reinmuth N, Hackanson B, Raab S, Fuchs F, Hildner K, Heudobler D. PMID: 42710204 [PubMed - as supplied by publisher]
	Topologically distinct intratumoral heterogeneity scores for predicting high-risk pathological grades in invasive lung adenocarcinoma: A multicenter study across four institutions. PLOS Digit Health Lin S, Mao Y, He Q, Qi W, Zhang S, Li W, Zuo Z. PMID: 42709716 [PubMed]
	Primary pulmonary salivary gland-type tumors in cytopathology practice: A systematic review and meta-analysis. Cancer Cytopathol Lagerstam H, Kalfert D, Kholová I. PMID: 42708877 [PubMed - indexed for MEDLINE]
	Economic value and clinical role of minimally invasive, biopsy-based diagnostics in non-small cell lung cancer. Cancer Cytopathol Guo J, Franzén B, Lewensohn R, Hysek M, Jönsson L. PMID: 42708823 [PubMed - indexed for MEDLINE]
	Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy. Pak J Pharm Sci Ju Z, Wu Y, Tian L, Shen D, Wang R. PMID: 42708777 [PubMed - indexed for MEDLINE]
	Environmental and occupational exposure in newly diagnosed lung cancer- data from the PROTEON study. Expert Rev Respir Med Sibille A, Hendrick J, Cue Alvarez A, Ernst M, Seidel L, Duysinx B, Louis R, Corhay JL. PMID: 42708503 [PubMed - as supplied by publisher]
	Identification of Causal Plasma Proteins and Immune Mediators for Lung Cancer in Never-Smokers: A Large-Scale Integrative Analysis Combining Mendelian Randomization, Colocalization, and Mediation. Curr Med Chem Wu JC, Zhang Q, Lin YM, Chen XR, Huang XB, Ye HY, Li J, Yang ZX, Wu QB, Su WM. PMID: 42708309 [PubMed - as supplied by publisher]
	The KEAP1-NFE2L2/NRF2 Axis in Non-Small Cell Lung Cancer Radioresistance: Redox Homeostasis and Emerging DNA Damage Response Mechanisms. Cancer Manag Res Jia X, Eerdemutu, Ren Y, Yang S, Yang C, Ding Q, Lin Y. PMID: 42708106 [PubMed]
	Family history of cancer and risk of lung cancer: a retrospective cohort study in a Chinese population. Front Med (Lausanne) Song H, Men X, Cheng J, Zhang L, Zhao S. PMID: 42707990 [PubMed]
	OLR1 as a Key Inflammatory Regulator Associated with Poor Response to Neoadjuvant Immunochemotherapy in Resectable Lung Cancer. J Inflamm Res Chen X, Zhang S, Ai X, Fan Y, Chen W. PMID: 42707646 [PubMed]
	Advances in understanding the mechanisms underlying acquired resistance to third-generation tyrosine kinase inhibitors in non-small cell lung cancer. Front Cell Dev Biol A-Lai GH, Li L, Ma G, Zhao YS, Yao P, Lin YD. PMID: 42707604 [PubMed]
	Mitochondrial niches of residual disease in EGFR-mutant NSCLC: immune-constrained persistence and therapeutic interception. Front Immunol Liang Z, Zhao X, Jiang M, Zhou M, Cheng M, Liu S, Zhao Y. PMID: 42707563 [PubMed - indexed for MEDLINE]
	Safety and quality of public chatbots for lung cancer prognostic information: a comparative evaluation. Front Public Health Jiang Y, Wang Q, Zheng L, Zhang L, Jiang B, Xu J, Wang J, Zhu J, Wu Z. PMID: 42707410 [PubMed - indexed for MEDLINE]
	Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer. Genes Chromosomes Cancer Köylü B, Genç N, Yücel MH, Y, A, K, Kemik F, Demir N, Bulutay P, Ölmez ÖF, Selçukbiricik F. PMID: 42706502 [PubMed - indexed for MEDLINE]
	Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer. Nat Commun Zhou F, Su C, Liang W, Xu LD, Tao W, Qian J, Xu S, Liu D, Fan R, Zhang Y, Liu Y, Wu L, Fu X, Zhang X, Shen N, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Chen W, He J, Zhou C. PMID: 42706268 [PubMed - indexed for MEDLINE]
	Unraveling lung cancer complexity: Spatial omics in tumor microenvironment characterization and precision medicine. Curr Probl Cancer Dasgupta S, Das S, Saha S. PMID: 42705130 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 162875

Seite 1 von 8144



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung